AMGN
Income statement / Annual
Last year (2023), Amgen Inc.'s total revenue was $28.19 B,
an increase of 7.09% from the previous year.
In 2023, Amgen Inc.'s net income was $6.72 B.
See Amgen Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$28.19 B
|
$26.32 B
|
$25.98 B
|
$25.42 B
|
$23.36 B
|
$23.75 B
|
$22.85 B
|
$22.99 B
|
$21.66 B
|
$20.06 B
|
| Cost of Revenue |
$8.45 B |
$6.41 B |
$6.45 B |
$6.16 B |
$4.36 B |
$4.10 B |
$4.07 B |
$4.16 B |
$4.23 B |
$4.42 B |
| Gross Profit |
$19.74 B |
$19.92 B |
$19.53 B |
$19.27 B |
$19.01 B |
$19.65 B |
$18.78 B |
$18.83 B |
$17.44 B |
$15.64 B |
| Gross Profit Ratio |
0.7 |
0.76 |
0.75 |
0.76 |
0.81 |
0.83 |
0.82 |
0.82 |
0.8 |
0.78 |
| Research and Development
Expenses |
$4.78 B
|
$4.43 B
|
$4.82 B
|
$4.21 B
|
$4.12 B
|
$3.74 B
|
$3.56 B
|
$3.84 B
|
$4.07 B
|
$4.30 B
|
| General & Administrative
Expenses |
$5.53 B
|
$4.57 B
|
$4.53 B
|
$4.77 B
|
$4.36 B
|
$5.33 B
|
$4.87 B
|
$5.06 B
|
$4.85 B
|
$4.70 B
|
| Selling & Marketing
Expenses |
$647.00 M
|
$841.00 M
|
$843.00 M
|
$962.00 M
|
$789.00 M
|
$674.00 M
|
$620.00 M
|
$489.00 M
|
$346.00 M
|
$0.00
|
| Selling, General &
Administrative Expenses |
$6.18 B
|
$5.41 B
|
$5.37 B
|
$5.73 B
|
$5.15 B
|
$5.33 B
|
$4.87 B
|
$5.06 B
|
$4.85 B
|
$4.70 B
|
| Other Expenses |
$9.33 B |
$503.00 M |
$194.00 M |
$189.00 M |
$66.00 M |
$314.00 M |
$375.00 M |
$133.00 M |
$49.00 M |
$454.00 M |
| Operating Expenses |
$11.88 B |
$10.35 B |
$10.38 B |
$10.13 B |
$9.33 B |
$9.38 B |
$8.81 B |
$9.04 B |
$8.97 B |
$9.45 B |
| Cost And Expenses |
$20.29 B |
$16.76 B |
$16.84 B |
$16.29 B |
$13.69 B |
$13.48 B |
$12.88 B |
$13.20 B |
$13.19 B |
$13.87 B |
| Interest Income |
$0.00 |
$1.41 B |
$1.20 B |
$256.00 M |
$753.00 M |
$674.00 M |
$928.00 M |
$629.00 M |
$603.00 M |
$465.00 M |
| Interest Expense |
$2.88 B |
$1.41 B |
$1.20 B |
$1.26 B |
$1.29 B |
$1.39 B |
$1.30 B |
$1.26 B |
$1.10 B |
$1.07 B |
| Depreciation &
Amortization |
$4.07 B
|
$3.26 B
|
$3.40 B
|
$3.60 B
|
$2.21 B
|
$1.95 B
|
$1.90 B
|
$2.11 B
|
$2.11 B
|
$2.09 B
|
| EBITDA |
$12.24 B
|
$12.09 B
|
$12.54 B
|
$12.93 B
|
$12.63 B
|
$12.88 B
|
$12.80 B
|
$11.94 B
|
$11.13 B
|
$8.75 B
|
| EBITDA Ratio |
0.43 |
0.33 |
0.36 |
0.37 |
0.45 |
0.46 |
0.48 |
0.45 |
0.42 |
0.33 |
| Operating Income Ratio
|
0.28
|
0.2
|
0.23
|
0.23
|
0.41
|
0.43
|
0.44
|
0.43
|
0.39
|
0.31
|
| Total Other
Income/Expenses Net |
-$42.00 M
|
$2.01 B
|
$696.00 M
|
-$1.01 B
|
-$536.00 M
|
-$718.00 M
|
-$376.00 M
|
-$631.00 M
|
-$492.00 M
|
-$606.00 M
|
| Income Before Tax |
$7.86 B |
$7.35 B |
$6.70 B |
$8.13 B |
$9.14 B |
$9.55 B |
$9.60 B |
$9.16 B |
$7.98 B |
$5.59 B |
| Income Before Tax Ratio
|
0.28
|
0.28
|
0.26
|
0.32
|
0.39
|
0.4
|
0.42
|
0.4
|
0.37
|
0.28
|
| Income Tax Expense |
$1.14 B |
$794.00 M |
$808.00 M |
$869.00 M |
$1.30 B |
$1.15 B |
$7.62 B |
$1.44 B |
$1.04 B |
$427.00 M |
| Net Income |
$6.72 B |
$6.55 B |
$5.89 B |
$7.26 B |
$7.84 B |
$8.39 B |
$1.98 B |
$7.72 B |
$6.94 B |
$5.16 B |
| Net Income Ratio |
0.24 |
0.25 |
0.23 |
0.29 |
0.34 |
0.35 |
0.09 |
0.34 |
0.32 |
0.26 |
| EPS |
12.56 |
12.18 |
10.34 |
12.4 |
12.96 |
12.7 |
2.71 |
10.32 |
9.15 |
6.8 |
| EPS Diluted |
12.49 |
12.11 |
10.28 |
12.31 |
12.88 |
12.62 |
2.69 |
10.24 |
9.06 |
6.7 |
| Weighted Average Shares
Out |
$535.00 M
|
$538.00 M
|
$570.00 M
|
$586.00 M
|
$605.00 M
|
$661.00 M
|
$731.00 M
|
$748.00 M
|
$758.00 M
|
$759.00 M
|
| Weighted Average Shares
Out Diluted |
$538.00 M
|
$541.00 M
|
$573.00 M
|
$590.00 M
|
$609.00 M
|
$665.00 M
|
$735.00 M
|
$754.00 M
|
$766.00 M
|
$770.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
